GDPR at Optimapharm

For Optimapharm, data protection and privacy are critical to our business and a top priority for our organization. Our commitment to handling data responsibly and respecting privacy is core to our way of doing business.
As you may be aware, new data protection rules in the European Union (EU) known as the General Data Protection Regulation (GDPR) are in effect as of May 25, 2018. Focused on data privacy, GDPR is the new EU legal framework for the protection of personal data. It includes several key changes to existing EU data protection law, including data breach notification, accountability and enhanced individual rights. GDPR affects all organizations and public bodies, wherever located, that handle data of persons in the EU.
The core aspect of Optimapharm’s business is information related to the provision of clinical trials management or related services for the pharmaceutical and biotech industry corresponding to human clinical research studies. Given the nature of our work, the protection of personal data is critical for our company and our customers. For these reasons, Optimapharm has a comprehensive privacy program designed to respect and protect data privacy rights.
For more information, please refer to Optimapharm DATA PRIVACY STATEMENT or contact us at: